101 related articles for article (PubMed ID: 17417785)
1. High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.
Hensel M; Zoz M; Giesecke C; Benner A; Neben K; Jauch A; Stilgenbauer S; Ho AD; Krämer A
Int J Cancer; 2007 Sep; 121(5):978-83. PubMed ID: 17417785
[TBL] [Abstract][Full Text] [Related]
2. The presence of high-risk chromosome aberrations in chronic lymphocytic leukaemia does not correlate with centrosome aberrations.
Ottaggio L; Zunino A; Maric I; Grozio A; Rossi E; Spriano M; Viaggi S
Hematol Oncol; 2008 Mar; 26(1):39-42. PubMed ID: 18050363
[TBL] [Abstract][Full Text] [Related]
3. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
4. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
5. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
[TBL] [Abstract][Full Text] [Related]
6. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
8. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
9. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
[TBL] [Abstract][Full Text] [Related]
10. Sex chromosome loss may represent a disease-associated clonal population in chronic lymphocytic leukemia.
Chapiro E; Antony-Debre I; Marchay N; Parizot C; Lesty C; Cung HA; Mathis S; Grelier A; Maloum K; Choquet S; Azgui Z; Uzunov M; Leblond V; Merle-Beral H; Sutton L; Davi F; Nguyen-Khac F
Genes Chromosomes Cancer; 2014 Mar; 53(3):240-7. PubMed ID: 24424752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
12. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability.
Giehl M; Fabarius A; Frank O; Hochhaus A; Hafner M; Hehlmann R; Seifarth W
Leukemia; 2005 Jul; 19(7):1192-7. PubMed ID: 15858613
[TBL] [Abstract][Full Text] [Related]
13. Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations.
Herishanu Y; Kay S; Joffe E; Ben-Ezra J; Baron S; Rotman R; Braunstein R; Dezorella N; Polliack A; Naparstek E; Perry C; Deutsch V; Katz BZ
Leuk Res; 2014 Apr; 38(4):484-9. PubMed ID: 24565568
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
15. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease.
D'Arena G; Laurenti L; Minervini MM; Deaglio S; Bonello L; De Martino L; De Padua L; Savino L; Tarnani M; De Feo V; Cascavilla N
Leuk Res; 2011 Mar; 35(3):363-8. PubMed ID: 20880586
[TBL] [Abstract][Full Text] [Related]
18. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.
Kern W; Bacher U; Haferlach C; Dicker F; Alpermann T; Schnittger S; Haferlach T
Br J Haematol; 2012 Apr; 157(1):86-96. PubMed ID: 22224978
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]